slider-1

36 Australians are diagnosed with lung cancer every day.

Female-Scientist-Working-in-The-Lab,-Using-Computer-Screen-1127105013_2170x1385-extended

We focus on research and education to prevent, treat and cure thoracic cancers.

Our Commitment

At the Thoracic Oncology Group of Australasia (TOGA), we are committed to improving lung cancer treatment and survival. Through the design of world-class research and trials, we hope to give you access to advanced treatment.

Support us

Inspire lung cancer patients through funding research and trials. 

Impactful education

An education program to better equip you to implement new findings into your care.   

Join us

Be part of TOGA and share a mission to prevent, treat, and cure thoracic cancer.

Research ideas

Our expert review process assists in developing high-quality funding applications.

Key Statistics About Thoracic Cancer

Every

0

minutes

a person living with lung cancer in Australia loses their life.

0 +

healthcare

professionals

empowered to integrate research findings into standard of care.

0

patients

were tested during the ASPiRATION trial, resulting in life-saving interventions.

TOGA Events

TOGA Lung Cancer Preceptorship

A two-day workshop with an intensive and active learning program for medical trainees, fellows and nurses interested in
22-23 November 2024

TOGA Post International Conference Highlights 2024

Highlights from the 2024 IASLC World Conference on Lung Cancer (WCLC), European Society for Medical Oncology (ESMO) Congress,
6:30 pm
15-16 October 2024

New Horizons In ES-SCLC

A meeting proudly sponsored by Amgen, focusing on current treatments and future therapies for Extensive Stage Small Cell
August 12, 2024
6:30 pm

Featured News

The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
We are pleased to announce some exciting changes to the TOGA Board of Directors.
Experience Kosi with Nick Pavlakis and the TOGA team to help fundraise for lung cancer research.
ALK Positive Australia Inc. and the Thoracic Oncology Group of Australia (TOGA) are honoured to announce a new grant partnership dedicated to advancing ALK+ NSCLC